Clinical Trial Update: A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of IW-3300 for bladder pain associated with interstitial cystitis/bladder pain syndrome has been terminated; no efficacy results are provided in t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Pain Syndrome
• Interstitial Cystitis

Drugs mentioned

• IW-3300

Snippet

Sponsor: Ironwood Pharmaceuticals, Inc. | Conditions: Interstitial Cystitis, Bladder Pain Syndrome | Phase 2 | Status: TERMINATED